Caraco announces reduction of its Board of Directors.DETROIT, Mich.--(HealthWire)--Sept. 19, 1996--Caraco Pharmaceutical Laboratories, Ltd. (BULLETIN BOARD: CARA) today announced that it has reduced its Board of Directors from 11 to 7 members. In doing so Caraco accepted resignations from Betty R. Anderson, Ronald R. Dobbins, William R. Hurd Hurd - The Hurd will be the foundation of the whole GNU system. It is built on top of the Mach 3.0 kernel, a free message-passing kernel developed by CMU. Mach's virtual memory management and message-passing facilities are extensively used by the Hurd. The GNU C Library will provide the Unix system call interface, and will call the Hurd for needed services it can't provide itself. One goal of the Hurd is to establish a framework for shared development and maintenance., Theodore H. Glenn, and Robert P. Roselle Roselle (rōzĕl`), borough (1990 pop. 20,314), Union co., NE N.J.; set off from Linden 1890 and inc. 1894. Chiefly residential, the borough has some industry. Thomas Edison had a laboratory there, and Roselle was the world's first community to have incandescent bulbs light its streets.. Present directors include David W. Adamany, C. Arnold Curry, Cara J. Curry, David A. Hagelstein, Jay F. Joliat and John R. Morris. Dr. Phyllis Harrison-Ross was elected to Caraco's Board as its seventh member. Dr. Harrison-Ross has more than 25 years in the community mental health profession. She presents a remarkably diverse career as a hospital administrator, researcher, academician, public health consultant, forensic psychiatrist and public educator. Dr. Harrison-Ross trained as an adult and child psychiatrist as well as a pediatrician, and continues to lend her administrative and clinical talents to serving the diverse, hard-to-reach and underserved population of New York. Caraco's Board stated that Dr. Harrison-Ross is a welcome addition to the Board. Her broad background will bring valuable perspective and insights to the company and will help fashion the future plans of Caraco. Caraco Pharmaceutical Laboratories, Ltd. is engaged in developing, manufacturing and marketing generic drugs for the ethical and over-the-counter markets. In August 1995, the company signed a distribution agreement with leading pharmaceutical and health care product distributor McKesson Drug Company, a subsidiary of $13 billion McKesson Corp. (NYSE:MCK), which provides Caraco with access to McKesson's existing distribution networks. Among Caraco's 14 generic products, are Nifedipine nifedipine /ni·fed·i·pine/ (ni-fed´i-pen) a calcium channel blocking agent used as a coronary vasodilator in the treatment of coronary insufficiency and angina pectoris; also used in the treatment of hypertension. ni·fed·i·pine (n, a calcium blocker for the cardiovascular market, SureLac(TM), a lactase lactase /lac·tase/ (lak´tas) a ß-galactosidase occurring in the brush border membrane of the intestinal mucosa that catalyzes the cleavage of lactose to galactose and glucose; it is part of the ß-glycosidase enzyme complex. lac·tase (l enzyme tablet which permits enjoyment of dairy products without discomfort, and additional products used for pain relief, sleeplessness, and coughs and colds. CONTACT: Caraco Pharmaceutical Laboratories, Ltd., Detroit William R. Hurd, 313/871-8400 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion